Rating History for Acadia Pharmaceuticals (ACAD) by BofA Securities

More Stocks Rated by BofA Securities | Latest Ratings for ACAD
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/25/2026 Tazeen Ahmad Upgrade Buy
(Neutral)		 29.00
(N/A)		 20.96
(21.09)		 0.62% Details